Approval · Notice of Compliance 2584 · 2001
MERIDIA: Notice of Compliance 2584
Issued May 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2584
- Date
- May 30, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer's name
- Therapeutic class
- Anorexiant/antiobesity agent
Products in this notice
Medicinal ingredients
- SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 10 MG per CAP
- SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 15 MG per CAP